Dementia prevention and reserve against neurodegenerative disease
- PMID: 31607780
- PMCID: PMC6780359
- DOI: 10.31887/DCNS.2019.21.1/rperneczky2
Dementia prevention and reserve against neurodegenerative disease
Abstract
Similar to other complex disorders, the etiology of Alzheimer disease is multifactorial and characterized by an interplay of biological and environmental risk and protective factors. Potentially modifiable risk factors have emerged from epidemiological research and strategies to prevent neurodegeneration and dementia are currently being tested, including multimodal interventions aiming to reduce several risk factors at once. The concept of reserve was developed based on the observation that certain individual characteristics, such as life experiences, lifestyles, and neurobiological parameters, are associated with a higher resilience against neurodegeneration and its symptoms. Coordinated research is required to maximize the use of available human and financial resources to better understand the underlying neurobiological mechanisms of reserve and to translate research findings into effective public health interventions.
Keywords: Alzheimer disease; brain reserve; cognitive reserve; dementia; epidemiology; mild cognitive impairment; prevention; protective factor; resilience.
Copyright: © 2019 AICH - Servier Group. All rights reserved.
Similar articles
-
Translational research on reserve against neurodegenerative disease: consensus report of the International Conference on Cognitive Reserve in the Dementias and the Alzheimer's Association Reserve, Resilience and Protective Factors Professional Interest Area working groups.BMC Med. 2019 Feb 27;17(1):47. doi: 10.1186/s12916-019-1283-z. BMC Med. 2019. PMID: 30808345 Free PMC article.
-
[Cognitive reserve and its relevance for the prevention and diagnosis of dementia].Nervenarzt. 2011 Mar;82(3):325-30, 332-35. doi: 10.1007/s00115-010-3165-7. Nervenarzt. 2011. PMID: 20938631 Review. German.
-
Cognitive Reserve and the Prevention of Dementia: the Role of Physical and Cognitive Activities.Curr Psychiatry Rep. 2016 Sep;18(9):85. doi: 10.1007/s11920-016-0721-2. Curr Psychiatry Rep. 2016. PMID: 27481112 Free PMC article. Review.
-
Reserve mechanisms in neurodegenerative diseases: from bench to bedside and back again.Curr Med Chem. 2012;19(36):6112-8. Curr Med Chem. 2012. PMID: 23072353 Review.
-
[Reserva cognitiva y demencias: Limitaciones del efecto protector en el envejecimiento y el deterioro cognitivoLimited protective effects of cognitive reserve on the progression of cognitive impairment].Rev Med Chil. 2019 Dec;147(12):1594-1612. doi: 10.4067/S0034-98872019001201594. Rev Med Chil. 2019. PMID: 32186624 Spanish.
Cited by
-
Modifiable contributing factors to COVID-19: A comprehensive review.Food Chem Toxicol. 2023 Jan;171:113511. doi: 10.1016/j.fct.2022.113511. Epub 2022 Nov 28. Food Chem Toxicol. 2023. PMID: 36450305 Free PMC article. Review.
-
Application of Natural Products in Neurodegenerative Diseases by Intranasal Administration: A Review.Pharmaceutics. 2025 May 20;17(5):675. doi: 10.3390/pharmaceutics17050675. Pharmaceutics. 2025. PMID: 40430965 Free PMC article. Review.
-
Are Advanced Clinical Practitioners perfectly placed to re-report neuroimages to support clinical diagnosis of dementia?Int J Adv Pract. 2023 Oct 2;1(3):146-150. doi: 10.12968/ijap.2023.1.3.146. Int J Adv Pract. 2023. PMID: 38229770 Free PMC article.
-
Shared (epi)genomic background connecting neurodegenerative diseases and type 2 diabetes.World J Diabetes. 2020 May 15;11(5):155-164. doi: 10.4239/wjd.v11.i5.155. World J Diabetes. 2020. PMID: 32477452 Free PMC article. Review.
-
Alpha-lipoic acid ameliorates tauopathy-induced oxidative stress, apoptosis, and behavioral deficits through the balance of DIAP1/DrICE ratio and redox homeostasis: Age is a determinant factor.Metab Brain Dis. 2021 Apr;36(4):669-683. doi: 10.1007/s11011-021-00679-7. Epub 2021 Feb 6. Metab Brain Dis. 2021. PMID: 33547995
References
-
- WHO Clinical Consortium on Healthy Ageing 2017 - report of consortium meeting 21 and 22 November 2017 in Geneva, Switzerland. Geneva: 2018
-
- Kane R, Butler M, Fink H, et al. Interventions To Prevent Age-Related Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer's-Type Dementia. Comparative Effectiveness Review No. 188. [Prepared by the Minnesota Evidence-based Practice Center under Contract No. 290-2015-00008-I]. AHRQ Publication No. 17-EHC008-EF. Rockville, MD: 2017
-
- Andrieu S, Guyonnet S, Coley N, et al. Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial. Lancet Neurol. 2017;16(5):377–389. - PubMed
-
- Moll van Charante EP, Richard E, Eurelings ES, et al. Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial. Lancet. 2016;388(10046):797–805. - PubMed
-
- Ngandu T, Lehtisalo J, Solomon A, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet. 2015;385(9984):2255–2263. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical